ArticleDiscover oncology2026
Type I neurofibromatosis with a solid pseudopapillary neoplasm of the pancreas: a case report and literature review.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundNeurofibromatosis type 1 (NF1) is associated with various pancreatic tumors. Pancreatic tumors in NF1 are most frequently neuroendocrine tumors (NETs) and less commonly. To date, no cases of NF1 combined with solid pseudopapillary neoplasm of the pancreas (SPN) have been reported. This case report provides the first detailed description of the diagnosis and treatment process of a patient with NF1 combined with pancreatic SPN. By presenting this case, we aim to offer clinicians practical experience and valuable insights to enhance the medical community's recognition and understanding of this rare disease. CASE PRESENTATION: This paper reports a 13-year-old female patient who was diagnosed with NF1 by genetic testing. The pancreatic head mass was found via whole-body MRI screening and was diagnosed as SPN via endoscopic ultrasound-guided fine needle aspiration biopsy. For this patient, our center 's plan is : the patient 's unresectable facial plexiform neurofibroma is treated with the targeted drug Smetitinib, and the patient 's pancreatic head tumor is treated with laparoscopic pancreatic tumor resection. The postoperative recovery was smooth, and there was no disease progression during the 6-month follow-up period. Combined with this case report, we also reviewed the literature concerning NF1 combined with pancreatic tumors.
conclusionTo our knowledge, this represents the first reported case of neurofibromatosis type 1 (NF1) associated with a solid pseudopapillary neoplasm of the pancreas (SPN). We also reviewed the characteristics of pancreatic tumors in NF1 patients reported in the literature. Combined with this case, we propose that pancreatic endocrine tumors may be one of the particularly rare clinical manifestations in patients with NF1, although further data analysis and molecular mechanism verification are needed. Nevertheless, this case provides valuable inspiration for the diagnosis and treatment of similar cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.